Replies to post #132530 on Amarin Corp Plc (AMRN)

[ziploc_1]

James....."I spoke to my broker last week and I said I thought Amrn had 60/40 chance of approval.He said You are to exposed to this stock and need to sell 50% percent asap"

Your broker is facing two definite positive events,by giving you this advise.....He gets a commission from your sale of Amarin and also from when you buy something else with the proceeds from the Amarin sale....He faces only one potentially negative event....i.e. losing you as a client after R-IT comes through with an excellent report in the next month or two.....I think he is taking a larger risk than you are.

[FlyFishingStocks]

JM, I agree. This chart does too.

Oct. 2014 and Feb. 2016 were the only two times when we saw bearish momentum as strong as it is now.



Price behavior at support and resistance presages trial result failure or success. Why? because someone knows if something is wrong with the trial - especially with this trial that has been already unlocked/blinded 2 times.
BCRX is a good example comparable to AMRN. Both saw tops followed by sell offs that took prices below the important support of the 200(white), 50(orange) and 20-day moving averages during their respective 'run downs' to announcement.


(the inserts on both charts are nearly identical)

Further evidence of trouble can be found on the comparison chart with IBB


Note the sharp dislocation between the two (pink highlight).

If you are still not sure, look at recent trial announcements that succeeded and failed. Successful ones saw prices above these key averages pre-announcement and vice versa for failed trials.

Cheerleaders might, but numbers don't lie. Think twice about holding AMRN if this TA weakness is magnified in the coming weeks. JMHO

FFS

[rafunrafun]

$36.We are $33 away from that figure

Number was just a random example, I could have used $11 or $120.

None of the big guys want to buy this stock $2.98.

Baker Brothers disagree with you.

I think we need to put it to guys like JL in the know science wise what they see percentage wise on this stock getting approval?

Does it really matter to you if JL says 97% or 42%?